TY - JOUR
T1 - Alfacalcidol enhances collagen quality in ovariectomized rat bones
AU - Nagaoka, Hideaki
AU - Terajima, Masahiko
AU - Yamada, Shizuka
AU - Azuma, Yoshiaki
AU - Chida, Takayuki
AU - Yamauchi, Mitsuo
PY - 2014/8
Y1 - 2014/8
N2 - The aim of this study was to investigate the effects of alfacalcidol (1α(OH)D3: ALF) on bone collagen employing an ovariectomized rat model. Thirty-five 16-week-old female Sprague-Dawley rats were divided into five groups: SHAM (sham-operated-+-vehicle), OVX (ovariectomy-+-vehicle), and three ALF-treated groups, that is, ovariectomy-+-0.022-μg/kg/day ALF, ovariectomy-+-0.067-μg/kg/day ALF, and ovariectomy-+-0.2-μg/kg/day ALF. After 12 weeks of treatment, tibiae were subjected to histological, biochemical and immunohistochemical analyses. Collagen matrices in OVX bone appeared as immature and poorly organized; however, with the ALF treatment, it was improved in a dose-dependent manner. Contents of collagen and pyridinoline cross-link were decreased in OVX compared with SHAM, but they increased to the level comparable to SHAM in ALF-treated groups. The total aldehyde, that is, a sum of free and those involved cross-links, in the highest dose of ALF was significantly higher than the rest of the groups (p-<-0.05). In addition, the expression of lysyl oxidase was increased in the all ALF-treated groups compared with OVX (p-<-0.05). In conclusion, ALF increases not only the amount of collagen but also enhances the maturation of collagen in ovariectomy-induced osteoporotic bones, which likely contributes to the improvement of bone quality.
AB - The aim of this study was to investigate the effects of alfacalcidol (1α(OH)D3: ALF) on bone collagen employing an ovariectomized rat model. Thirty-five 16-week-old female Sprague-Dawley rats were divided into five groups: SHAM (sham-operated-+-vehicle), OVX (ovariectomy-+-vehicle), and three ALF-treated groups, that is, ovariectomy-+-0.022-μg/kg/day ALF, ovariectomy-+-0.067-μg/kg/day ALF, and ovariectomy-+-0.2-μg/kg/day ALF. After 12 weeks of treatment, tibiae were subjected to histological, biochemical and immunohistochemical analyses. Collagen matrices in OVX bone appeared as immature and poorly organized; however, with the ALF treatment, it was improved in a dose-dependent manner. Contents of collagen and pyridinoline cross-link were decreased in OVX compared with SHAM, but they increased to the level comparable to SHAM in ALF-treated groups. The total aldehyde, that is, a sum of free and those involved cross-links, in the highest dose of ALF was significantly higher than the rest of the groups (p-<-0.05). In addition, the expression of lysyl oxidase was increased in the all ALF-treated groups compared with OVX (p-<-0.05). In conclusion, ALF increases not only the amount of collagen but also enhances the maturation of collagen in ovariectomy-induced osteoporotic bones, which likely contributes to the improvement of bone quality.
KW - alfacalcidol
KW - collagen
KW - collagen cross-link
KW - ovariectomized rats
KW - vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84903272886&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903272886&partnerID=8YFLogxK
U2 - 10.1002/jor.22642
DO - 10.1002/jor.22642
M3 - Article
C2 - 24809324
AN - SCOPUS:84903272886
SN - 0736-0266
VL - 32
SP - 1030
EP - 1036
JO - Journal of Orthopaedic Research
JF - Journal of Orthopaedic Research
IS - 8
ER -